Show simple item record

dc.contributor.authorMoretti, Nilmar Silvio [UNIFESP]
dc.contributor.authorAugusto, Leonardo da Silva [UNIFESP]
dc.contributor.authorClemente, Tatiana Mordente [UNIFESP]
dc.contributor.authorAntunes, Raysa Paes Pinto [UNIFESP]
dc.contributor.authorYoshida, Nobuko [UNIFESP]
dc.contributor.authorTorrecilhas, Ana Claudia
dc.contributor.authorCano, Maria Isabel Nogueira
dc.contributor.authorSchenkman, Sergio [UNIFESP]
dc.date.accessioned2021-11-29T12:42:07Z
dc.date.available2021-11-29T12:42:07Z
dc.date.issued2015
dc.identifier.urihttps://repositorio.unifesp.br/xmlui/handle/11600/62320
dc.description.abstractAcetylation of lysine is a major posttranslational modification of proteins and is catalyzed by lysine acetyltransferases, while lysine deacetylases remove acetyl groups. Among the deacetylases, the sirtuins are NAD(+)-dependent enzymes, which modulate gene silencing, DNA damage repair, and several metabolic processes. As sirtuin-specific inhibitors have been proposed as drugs for inhibiting the proliferation of tumor cells, in this study, we investigated the role of these inhibitors in the growth and differ- entiation of Trypanosoma cruzi, the agent of Chagas disease. We found that the use of salermide during parasite infection pre- vented growth and initial multiplication after mammalian cell invasion by T. cruzi at concentrations that did not affect host cell viability. In addition, in vivo infection was partially controlled upon administration of salermide. There are two sirtuins in T. cruzi, TcSir2rp1 and TcSir2rp3. By using specific antibodies and cell lines overexpressing the tagged versions of these enzymes, we found that TcSir2rp1 is localized in the cytosol and TcSir2rp3 in the mitochondrion. TcSir2rp1 overexpression acts to impair parasite growth and differentiation, whereas the wild-type version of TcSir2rp3 and not an enzyme mutated in the active site improves both. The effects observed with TcSir2rp3 were fully reverted by adding salermide, which inhibited TcSir2rp3 ex- pressed in Escherichia coli with a 50% inhibitory concentration (IC50) ± standard error of 1 ± 0.5 μM. We concluded that sir- tuin inhibitors targeting TcSir2rp3 could be used in Chagas disease chemotherapy.pt_BR
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)pt_BR
dc.languageengpt_BR
dc.publisherASMpt_BR
dc.relation.ispartofAntimicrobial Agents and Chemotherapypt_BR
dc.rightsAcesso abertopt_BR
dc.subjectT cruzipt_BR
dc.subjectSirtuinspt_BR
dc.titleCharacterization of Trypanosoma cruzi Sirtuins as possible drug targets for Chagas diseasept_BR
dc.typeArtigopt_BR
dc.description.sponsorshipIDFAPESP: 2012/09403-8pt_BR
dc.description.sponsorshipIDFAPESP: 2013/16211-0pt_BR
dc.description.sponsorshipIDFAPESP: 2011/51973-3pt_BR
dc.identifier.doidoi:10.1128/AAC.04694-14pt_BR
unifesp.campusEscola Paulista de Medicina (EPM)pt_BR
unifesp.graduateProgramMicrobiologia e Imunologiapt_BR
unifesp.knowledgeAreaOutrapt_BR
dc.contributor.authorLatteshttp://lattes.cnpq.br/2131472726202687pt_BR
dc.citation.volume59
dc.citation.issue8
dc.citation.epage4669-79
unifesp.departamentoMicrobiologia, Imunologia e Parasitologiapt_BR


Files in this item

This item appears in the following Collection(s)

Show simple item record